Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature

Paolo Bossi, Salvatore Alfieri, Primoz Strojan, Robert P. Takes, Fernando López, Antti Mäkitie, Nabil F. Saba, Juan Pablo Rodrigo, Carol Bradford, Carlos Suarez, Mark Zafereo, Arlene A. Forastiere, Jan B. Vermorken, Miquel Quer, Alvaro Sanabria, Ricard Simo, Remco de Bree, Alessandra Rinaldo, Alfio Ferlito

Research output: Contribution to journalReview article

Abstract

The pattern of clinical behaviour and response to treatment of recurrent and/or metastatic head and neck squamous cell carcinoma is heterogeneous. Treatment strategies that can be employed vary from potentially curative salvage surgery and re-irradiation to palliative systemic therapies and best supportive care. The advent of new therapeutic options, in terms of more sophisticated surgical approaches and techniques, highly conformal and precise radiation techniques and immunotherapy may offer improved control of disease and longer survival. Moreover, the epidemiological changes during the last decades, including the increase of human papilloma virus-related oropharyngeal primary tumors, are also reflected in the recurrent and metastatic setting. In this complex context the identification of predictive and prognostic factors is urgently needed to tailor treatment, to increase its efficacy, and to avoid unnecessary toxicities. A better knowledge of prognosis may also help the patients and caregivers in decision making on the optimal choice of care. The purpose of our review is to highlight the current evidence and shortcomings in this field.

Original languageEnglish (US)
Pages (from-to)84-91
Number of pages8
JournalCritical Reviews in Oncology/Hematology
Volume137
DOIs
StatePublished - May 1 2019

Fingerprint

Papillomaviridae
Therapeutics
Palliative Care
Immunotherapy
Caregivers
Decision Making
Radiation
Survival
Carcinoma, squamous cell of head and neck
Neoplasms
Re-Irradiation

Keywords

  • Head and neck cancer
  • Prognostic and predictive factors
  • Recurrent and/or metastatic disease

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma : A review of the literature. / Bossi, Paolo; Alfieri, Salvatore; Strojan, Primoz; Takes, Robert P.; López, Fernando; Mäkitie, Antti; Saba, Nabil F.; Rodrigo, Juan Pablo; Bradford, Carol; Suarez, Carlos; Zafereo, Mark; Forastiere, Arlene A.; Vermorken, Jan B.; Quer, Miquel; Sanabria, Alvaro; Simo, Ricard; de Bree, Remco; Rinaldo, Alessandra; Ferlito, Alfio.

In: Critical Reviews in Oncology/Hematology, Vol. 137, 01.05.2019, p. 84-91.

Research output: Contribution to journalReview article

Bossi, P, Alfieri, S, Strojan, P, Takes, RP, López, F, Mäkitie, A, Saba, NF, Rodrigo, JP, Bradford, C, Suarez, C, Zafereo, M, Forastiere, AA, Vermorken, JB, Quer, M, Sanabria, A, Simo, R, de Bree, R, Rinaldo, A & Ferlito, A 2019, 'Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature', Critical Reviews in Oncology/Hematology, vol. 137, pp. 84-91. https://doi.org/10.1016/j.critrevonc.2019.01.018
Bossi, Paolo ; Alfieri, Salvatore ; Strojan, Primoz ; Takes, Robert P. ; López, Fernando ; Mäkitie, Antti ; Saba, Nabil F. ; Rodrigo, Juan Pablo ; Bradford, Carol ; Suarez, Carlos ; Zafereo, Mark ; Forastiere, Arlene A. ; Vermorken, Jan B. ; Quer, Miquel ; Sanabria, Alvaro ; Simo, Ricard ; de Bree, Remco ; Rinaldo, Alessandra ; Ferlito, Alfio. / Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma : A review of the literature. In: Critical Reviews in Oncology/Hematology. 2019 ; Vol. 137. pp. 84-91.
@article{4f481bfc5e1a461fb99b0df48ef5af0f,
title = "Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature",
abstract = "The pattern of clinical behaviour and response to treatment of recurrent and/or metastatic head and neck squamous cell carcinoma is heterogeneous. Treatment strategies that can be employed vary from potentially curative salvage surgery and re-irradiation to palliative systemic therapies and best supportive care. The advent of new therapeutic options, in terms of more sophisticated surgical approaches and techniques, highly conformal and precise radiation techniques and immunotherapy may offer improved control of disease and longer survival. Moreover, the epidemiological changes during the last decades, including the increase of human papilloma virus-related oropharyngeal primary tumors, are also reflected in the recurrent and metastatic setting. In this complex context the identification of predictive and prognostic factors is urgently needed to tailor treatment, to increase its efficacy, and to avoid unnecessary toxicities. A better knowledge of prognosis may also help the patients and caregivers in decision making on the optimal choice of care. The purpose of our review is to highlight the current evidence and shortcomings in this field.",
keywords = "Head and neck cancer, Prognostic and predictive factors, Recurrent and/or metastatic disease",
author = "Paolo Bossi and Salvatore Alfieri and Primoz Strojan and Takes, {Robert P.} and Fernando L{\'o}pez and Antti M{\"a}kitie and Saba, {Nabil F.} and Rodrigo, {Juan Pablo} and Carol Bradford and Carlos Suarez and Mark Zafereo and Forastiere, {Arlene A.} and Vermorken, {Jan B.} and Miquel Quer and Alvaro Sanabria and Ricard Simo and {de Bree}, Remco and Alessandra Rinaldo and Alfio Ferlito",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.critrevonc.2019.01.018",
language = "English (US)",
volume = "137",
pages = "84--91",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma

T2 - A review of the literature

AU - Bossi, Paolo

AU - Alfieri, Salvatore

AU - Strojan, Primoz

AU - Takes, Robert P.

AU - López, Fernando

AU - Mäkitie, Antti

AU - Saba, Nabil F.

AU - Rodrigo, Juan Pablo

AU - Bradford, Carol

AU - Suarez, Carlos

AU - Zafereo, Mark

AU - Forastiere, Arlene A.

AU - Vermorken, Jan B.

AU - Quer, Miquel

AU - Sanabria, Alvaro

AU - Simo, Ricard

AU - de Bree, Remco

AU - Rinaldo, Alessandra

AU - Ferlito, Alfio

PY - 2019/5/1

Y1 - 2019/5/1

N2 - The pattern of clinical behaviour and response to treatment of recurrent and/or metastatic head and neck squamous cell carcinoma is heterogeneous. Treatment strategies that can be employed vary from potentially curative salvage surgery and re-irradiation to palliative systemic therapies and best supportive care. The advent of new therapeutic options, in terms of more sophisticated surgical approaches and techniques, highly conformal and precise radiation techniques and immunotherapy may offer improved control of disease and longer survival. Moreover, the epidemiological changes during the last decades, including the increase of human papilloma virus-related oropharyngeal primary tumors, are also reflected in the recurrent and metastatic setting. In this complex context the identification of predictive and prognostic factors is urgently needed to tailor treatment, to increase its efficacy, and to avoid unnecessary toxicities. A better knowledge of prognosis may also help the patients and caregivers in decision making on the optimal choice of care. The purpose of our review is to highlight the current evidence and shortcomings in this field.

AB - The pattern of clinical behaviour and response to treatment of recurrent and/or metastatic head and neck squamous cell carcinoma is heterogeneous. Treatment strategies that can be employed vary from potentially curative salvage surgery and re-irradiation to palliative systemic therapies and best supportive care. The advent of new therapeutic options, in terms of more sophisticated surgical approaches and techniques, highly conformal and precise radiation techniques and immunotherapy may offer improved control of disease and longer survival. Moreover, the epidemiological changes during the last decades, including the increase of human papilloma virus-related oropharyngeal primary tumors, are also reflected in the recurrent and metastatic setting. In this complex context the identification of predictive and prognostic factors is urgently needed to tailor treatment, to increase its efficacy, and to avoid unnecessary toxicities. A better knowledge of prognosis may also help the patients and caregivers in decision making on the optimal choice of care. The purpose of our review is to highlight the current evidence and shortcomings in this field.

KW - Head and neck cancer

KW - Prognostic and predictive factors

KW - Recurrent and/or metastatic disease

UR - http://www.scopus.com/inward/record.url?scp=85062812096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062812096&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2019.01.018

DO - 10.1016/j.critrevonc.2019.01.018

M3 - Review article

C2 - 31014517

AN - SCOPUS:85062812096

VL - 137

SP - 84

EP - 91

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

ER -